The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2016 | Improving strategies for executing successful clinical trials in multiple myeloma
Eric Low, Chief Executive of Myeloma UK, explains the evolving strategies for improving the drug development process for therapies for patients with multiple myeloma so that the right therapies are delivered to the right patients. One such strategy is the Myeloma UK’s Clinical Trial Network, which comprises of experts, hospitals and research centres across the UK aimed at accelerating the testing of and access to new myeloma therapies. Recorded at the 2016 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
